iAnthus Capital Holdings (CSE: IAN) (OTCQX: ITHUF) has reported several recent milestones in Massachusetts. The company’s Mayflower Medicinals was approved for a retail marijuana license by the City of Worcester License Commission to operate an adult-use dispensary. The company’s medical marijuana cultivation and processing facility in Holliston is supplying flower, pre-rolls, distillate, and edibles to Mayflower’s medical dispensary in Boston and to over 18 other medical dispensaries in the state on a wholesale basis. In addition, the company is finalizing its operating plans to open a second cultivation and processing facility in Massachusetts.
CannTrust Holdings (TSX: TRST) (NYSE: CTST) announced immediate senior management changes and other interim actions based on the ongoing investigation being undertaken by a special committee of its board of directors. The investigation into the company’s non-compliance with Health Canada regulations and ancillary matters uncovered new information that has resulted in a determination by the board to terminate with cause CEO Peter Aceto, according to a company statement.
Grown Rogue International (CSE: GRIN) (OTC: GRUSF) has announced the resignation of Adam Wolf as the company’s chief operating officer. The company did not disclose any reasons behind Wolf’s resignation.
Jushi Holdings (OTCMKTS:JSHHF) subsidiary Production Excellence has received local City of North Las Vegas approval to enter the Las Vegas market under a management services agreement with Franklin Bioscience NV. Under the agreement, Jushi has also completed the purchase of the real estate associated with Franklin Bioscience Nevada’s facility in North Las Vegas, Nevada.
Abba Medix, a subsidiary of Canada House Wellness Group (CSE: CHV) (OTCMKTS:SARSF), is working closely with Health Canada to amend its existing sales license to allow for the sale of its own cannabis. Once the amendment to its sales license is received, Abba plans to sell cannabis, including its own Abba Medix brand, in dried flower format, directly to registered medical patients and authorized provincial/territorial distributors and retailers across Canada.
SOL Global Investments (CSE: SOL) (OTCPK: SOLCF) (Frankfurt: 9SB) announced a US$2 million capital infusion in its portfolio company CannCure Investments. The investment will put a focus on the development of SOL’s California acquisitions, namely One Plant Dispensaries and Northern Emeralds, SOL said in a statement, noting the infusion is to speed up the construction and store opening process for One Plant dispensaries in California as well as to complete planned upgrades for Northern Emerald’s cultivation facilities and to improve Northern Emeralds distribution network and systems.
Gabriella’s Kitchen (CSE: GABY) (OTCQB: GABLF), a U.S.-focused CPG company operating in the regulated cannabis sector in California as well as the mainstream grocery channel nationally, has agreed to acquire all of the issued and outstanding membership interests of KJM Data and Research.
MYM Nutraceuticals (CSE: MYM) (OTCBB: MYMMF) has hired Ronan O’Neill as vice president of operations. O’Neill has more than 20-years of experience in the agricultural and food industries, including sales, business development, market research, and various management roles. He successfully started an international fresh produce export business that focuses on fresh fruit from BC Canada to customers worldwide, including European and Asian markets.
PharmaCielo Ltd. (TSXV: PCLO) (OTC: PHCEF), the Canadian parent of Colombia’s cultivator and producer of medicinal-grade cannabis extracts PharmaCielo Colombia Holdings S.A.S., announced that it has completed the necessary permitting process required to enable Colombia’s first commercial export and sale of non-psychoactive (CBD) isolate.
